Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Cystic fibrosis, Medicine, Internal medicine, Ivacaftor, Phenotype, and Excretion.
Elexacaftor/tezacaftor/ivacaftor corrects salt-wasting in cystic fibrosis
Elexacaftor/Tezacaftor/Ivacaftor (ETI) Treatment Corrects the Salt-Losing Phenotype in People with Cystic Fibrosis
WS04.03 Elexacaftor/tezacaftor/ivacaftor (ETI) treatment corrects the salt-losing phenotype in people with cystic fibrosis (pwCF)
Impaired Renal HCO3 - Excretion in Cystic Fibrosis
The Cystic Fibrosis Urine Test
2019cited by 0position: middle